AVTX — Avalo Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Avalo Therapeutics Inc (AVTX), worth $7.34M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $6.60M | 0.00% | +197.4% |
| Persistent | $453.57K | 0.14% | +210% |
| Quadrature | $284.68K | 0.00% | -87.7% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.